Financial Daily from THE HINDU group of publications
Monday, Aug 02, 2004
Financial Daily from THE HINDU group of publications Monday, Aug 02, 2004 |
||
|
|
||
|
Corporate
-
Announcements Intas Pharma to launch series of biotech drugs Our Bureau
Chennai , Aug 1 FOUR years of biotech developmental work has put Intas Pharmaceuticals in a position to launch new products at six-month intervals, according to its officials. Intas' officials were in the city to promote the company's first biotech product, Neukine (Human Granulocyte Colony Stimulating Factor), used in treating cancer. Neukine would be followed by the launch of Erythropoietin and Interferon, they said. Intas' products would largely centre on the treatment of cancer, said Mr R. Chandrasekaran, Vice-President (Marketing). The company's manufacturing process has had a big say in the kind of products it plans to launch. Officials said the company would stick to products that required a "small scale" of manufacturing. The company has invested about Rs 40 crore-Rs 45 crore in the developmental work.
More Stories on : Announcements | Pharmaceuticals | Health | Bio-tech & Genetics
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|